Vitamin B12 (Cyanocobalamin) is fundamental for supporting cellular methylation, DNA stability, and one-carbon metabolism. Research shows that deficiency shifts the SAM/SAH balance and disrupts essential RNA and protein methylation pathways. It also increases multiple DNA damage markers across diverse biological systems. Both experimental and in vivo models consistently demonstrate its crucial role in protecting overall genome integrity.

AOD-9604 is a research-grade peptide used to study adipose-specific metabolism and neural mechanisms in obesity models. Preclinical studies highlight its phenotype-specific effects and selective lipolytic activity. Researchers can examine AMPK/PGC-1α, Nrf2, and BDNF/TrkB pathways with reliable, high-purity peptides. Using consistent materials ensures reproducible, controlled laboratory studies, enabling precise exploration of metabolic and neurobiological processes.

This research-focused article examines how AOD-9604 may impact metabolic brain pathways associated with obesity-related cognitive decline. It highlights emerging preclinical and clinical evidence, including support for neural metabolism, reduced neuroinflammation, and potential neuroprotective effects. Researchers studying adipose-brain signaling, metabolic peptides, and cognitive outcomes will find detailed insights, mechanisms, and CTA guidance for accessing high-purity AOD-9604 strictly for laboratory use.

This blog explores how NAD⁺-boosting peptides protect neurons during ischemic stroke by preserving energy, supporting mitochondria, and reducing oxidative stress. It highlights key mechanisms involving sirtuins, PARP regulation, and NAD⁺ salvage pathways, along with preclinical evidence validating these strategies in stroke models. Learn why high-purity research peptides are essential for advancing ischemia neuroprotection studies.